2023
DOI: 10.3389/fphar.2023.1176422
|View full text |Cite
|
Sign up to set email alerts
|

Nanoparticles as drug delivery systems in the treatment of oral squamous cell carcinoma: current status and recent progression

Abstract: Oral squamous cell carcinoma (OSCC) is a common human malignancy with an estimated incidence of around 377,713 new cases worldwide in 2020. Despite the advance in clinical management, some of OSCC patients still miss the opportunity of completable resection of tumor, and have to accept medical therapies, e.g., chemotherapy, radiotherapy, or immunotherapy when the disease develops into the advanced stage. However, these therapies have been reported to be far from ideal due to the low efficiency of conventional … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 78 publications
(101 reference statements)
0
1
0
Order By: Relevance
“…This emerging therapeutic approach utilizes nanomaterials either as carriers or photosensitizers (PS), opening new avenues for treatment [10]. Nanomaterials refer to particles with a sub-micrometer size that can selectively target the tumor cells [11]. This article will highlight the approach in the field of nanotechnology and its impact on treating premalignant lesions.…”
mentioning
confidence: 99%
“…This emerging therapeutic approach utilizes nanomaterials either as carriers or photosensitizers (PS), opening new avenues for treatment [10]. Nanomaterials refer to particles with a sub-micrometer size that can selectively target the tumor cells [11]. This article will highlight the approach in the field of nanotechnology and its impact on treating premalignant lesions.…”
mentioning
confidence: 99%